Technologies include drug delivery system and method of capturing marine energy
TAMPA, Fla. (Oct. 15, 2014) – STEM Genesis, LLC, has joined the Tampa Bay Technology Incubator, part of USF CONNECT at the University of South Florida.
“STEM Genesis identifies, develops, and commercializes early-stage technologies to help research make it past the university laboratory setting and into the marketplace,” said Dr. Michael Muthig, STEM Genesis president and CEO. “We focus on technologies that have moderate to high revenue potential, the ability to create new companies and high-tech jobs, and a commercialization path that has the potential of providing a solid return on investments for our stakeholders.”
Muthig and Jennifer Metz founded STEM Genesis (www.gostemgen.com) in 2014. Muthig has nearly 30 years of experience in technology commercialization with government labs, universities, private companies, and individual inventors. Metz has an extensive background in small business, entrepreneurial development, market research, and marketing.
The STEM Genesis portfolio currently includes three technologies. One is the PlazMed™ Drug Delivery System, which uses a charged stream of electrons to enhance delivery of drugs into target cells. “Such technology can open the door to new and more efficient treatments for cancer and infectious diseases,” said Muthig.
The second technology, the PlazMed™ Hair Removal System, is a patented technology that uses a stream of non-thermal electric current to remove hair. According to the STEM Genesis website, testing shows the technology is painless and causes no skin irritation or damage.
The third technology is the MudPowerTM Microbial Fuel Cell (MFC), which harnesses energy produced by microorganisms in marine sediments. “Currently used battery packs tend to be heavy and need to be replaced often. MFCs offer the potential for long term use of marine instruments in addition to the potential for enormous savings over the life of an instrument,” said Muthig.
The company establishes proof of concept, builds prototypes, and validates performance for young projects. Once potential risk is reduced through such testing, STEM Genesis uses private sources of capital, along with government funding, to advance a technology’s development. “Through our technology testing and risk assessment, we can increase a technology’s value, and attract commercialization partners,” said Muthig.
“The new partnership with STEM Genesis provides a platform to accelerate development, testing and commercialization of technologies from USF,” said Stephanie Ashley, USF Director of Innovation and Incubation Programs. “As part of the Tampa Bay Technology Incubator, STEM Genesis will have access to otherwise costly research equipment and facilities, as well as mentors to help them grow as a company.”
USF CONNECT focuses on the needs of Tampa Bay’s technology and bio/life sciences entrepreneurs throughout the business life cycle, providing the facilities, partners and resources for successful business development. USF CONNECT offers access to technologies, workforce programs, technology commercialization, critical research equipment, and incubator facilities, adding value and delivering targeted, high level expertise to its member businesses.
The Tampa Bay Technology Incubator (TBTI) is one vehicle through which USF CONNECT grows successful companies. TBTI supports technology research as a catalyst for economic development and advocates the creation and development of facilities for high-technology companies and related support functions.
The University of South Florida is a high-impact, global research university dedicated to student success. USF is a Top 50 research university among both public and private institutions nationwide in total research expenditures, according to the National Science Foundation. Serving nearly 48,000 students, the USF System has an annual budget of $1.5 billion and an annual economic impact of $4.4 billion. USF is a member of the American Athletic Conference and a charter institution of the National Academy of Inventors.